通过乳化剂的类型和度调节比格尔的性能:结构,物理化学和分子视角
Yi Xue1, Jinfeng Zhong1, Xiong Liu1
1College of Food Science, Southwest University, Chongqing 400715, China.
这项研究优化了使用甘油单酸盐 (GM) 和酸丁胆 (PC) 乳化剂的比格尔. 乳化剂的类型和度显著影响大的质地,稳定性和食品应用中的抗氧化特性.
科学领域:
- 食品科学和材料科学 食品科学和材料科学
- 合体和接口科学科学
背景情况:
- 由油凝和水凝相组成的比格尔,为食品应用提供可调节的特性.
- 控制大麦的物理特性和化学稳定性对于它们作为功能性脂肪替代品的使用至关重要.
研究的目的:
- 调查乳化剂类型 (甘油单酸盐-GM和酸丁胆-PC) 和度对大麦属性的影响.
- 为了增强比格尔的物理特性,微观结构和氧化稳定性.
主要方法:
- 使用乙烯纤维素油凝和脱乙酸康雅克葡萄甘水凝制造大饼.
- 分析物理特性 (油的结合能力,硬度,弹性),微观结构和氧化稳定性.
- 分子动力学模拟以阐明分子间相互作用.
主要成果:
- 低乳化剂度 (≤1%) 降低了油水界面张力,改善了大的均性和分散性.
- 转基因和PC增加了油的结合能力和弹性,但更高的度降低了硬度.
- 两种乳化剂都增强了氧化稳定性,转基因显示出卓越的抗氧化作用;分子动力学证实加强了分子间相互作用.
结论:
- 乳化剂的类型和度是调整比格尔纹理和稳定性的关键因素.
- 这些发现为设计具有定制性质的结构性食品材料提供了洞察力.
- 经过优化后的大面包显示出其作为食品中的功能性脂肪替代品的潜力.
更多相关视频
10:01Thermal Scanning Conductometry TSC as a General Method for Studying and Controlling the Phase Behavior of Conductive Physical Gels
Published on: January 23, 2018
06:48Tuning the Contractility and Deformation Modes of Active Actin-Based Assemblies In Vitro: From Two-Dimensional Active Networks to Liquid Crystal Drops
Published on: July 11, 2025
相关概念视频
Detergent Purification of Membrane Proteins
Silica Gel Column Chromatography: Overview
Polar components tend to bind strongly to the silica gel, causing them to move slowly through the column. In contrast, nonpolar compounds...
Molecular Weight of Step-Growth Polymers
As the step-growth polymerization involves step-wise condensation of monomers, the molecular weight also builds up eventually. Consequently, high molecular weight polymers are obtained at the late stages of the polymerization, where 99% of monomers have been consumed.
The extent of the...
Optimizing Chromatographic Separations
Band broadening refers to spreading solute bands as they travel through the column. This broadening can impact resolution. Plate height (H) represents the length required for one theoretical plate. A lower plate height corresponds to...
Classification and Mechanical Properties of Synthetic Polymers
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
